Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-0492
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy ; volume:6 ; number:1 ; day:26 ; month:2 ; year:2018 ; pages:1-8 ; date:12.2018
Journal of Intensive Care ; 6, Heft 1 (26.2.2018), 1-8, 12.2018
- Creator
-
Prohaska, Stefanie
- Contributor
-
Schirner, Andrea
Bashota, Albina
Körner, Andreas
Blumenstock, Gunnar
Haeberle, Helene A.
SpringerLink (Online service)
- DOI
-
10.1186/s40560-018-0278-8
- URN
-
urn:nbn:de:101:1-2018091001062914960113
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Prohaska, Stefanie
- Schirner, Andrea
- Bashota, Albina
- Körner, Andreas
- Blumenstock, Gunnar
- Haeberle, Helene A.
- SpringerLink (Online service)
Other Objects (12)
Optimierung der ECMO-Therapie bei schwerem ARDS
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
To prone or not to prone ARDS patients on ECMO
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Hämolyse bei Patientinnen und Patienten mit ARDS und Therapie mit ECMO
Use of ECMO in ARDS: does the EOLIA trial really help?
ECMO is associated with decreased hospital mortality in COVID-19 ARDS
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
Optimierung der ECMO-Therapie bei schwerem ARDS
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
To prone or not to prone ARDS patients on ECMO
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Hämolyse bei Patientinnen und Patienten mit ARDS und Therapie mit ECMO
Use of ECMO in ARDS: does the EOLIA trial really help?
ECMO is associated with decreased hospital mortality in COVID-19 ARDS
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
Optimierung der ECMO-Therapie bei schwerem ARDS
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
To prone or not to prone ARDS patients on ECMO
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Hämolyse bei Patientinnen und Patienten mit ARDS und Therapie mit ECMO
Use of ECMO in ARDS: does the EOLIA trial really help?
ECMO is associated with decreased hospital mortality in COVID-19 ARDS
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy